Search
Clinical Trials
A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 over 52 Weeks in Participants with Early Alzheimer’s Disease
STATUS: Active, Recruiting
New IDEAS: Imaging Dementia—Evidence for Amyloid Scanning Study
STATUS: Active, Recruiting
ENVISION
STATUS: Active, Recruiting
TRAILBLAZER-ALZ 3
STATUS: Active, Not Recruiting
Alzheimers (Alzheon ApolloE4)
STATUS: Active, Not Recruiting